Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

43

Revenue 2017

Perjeta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Perjeta was produced by Roche.

UK pharma rebate payment doubles in one year

UK pharma rebate payment doubles in one year First quarter repayment £138m higher than this time last year

Roche maintains dominance as leading cancer drugmaker

Roche maintains dominance as leading cancer drugmaker drugs such as its next-generation breast cancer drug Perjeta (pertuzumab). ... This was highlighted in England where last year the country's health technology assessor NICE said Perjeta was nearly double the price (at £90, 000) than it would consider

Roche adds kidney cancer to anti-PD-L1 programme

Roche adds kidney cancer to anti-PD-L1 programme Sales of the company's HER2-targeting drugs - Herceptin (trastuzumab) and follow-up therapies Perjeta (pertuzumab) and Kadcyla (trastuzumab emtansine) - grew 23% thanks to increased use of Herceptin and Perjeta in ... The growth of Perjeta - up 82% to

England's Cancer Drugs Fund: Fixing a broken system

England's Cancer Drugs Fund: Fixing a broken system The Swiss firm has, in relative terms at least, not come out too badly during the de-listing process as two of its newer cancer medicines, namely breast cancer treatments Perjeta

Roche's newer breast cancer drugs gain traction

Roche's newer breast cancer drugs gain traction Perjeta and Kadcyla boost 2014 revenues. Solid growth for Roche's breast cancer blockbuster Herceptin was backed up by big gains for two follow-up products in the last quarter for ... Roche's breast cancer franchise was particularly boosted by the

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics